TERN-201
- Generic Name
- TERN-201
AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic Steatohepatitis
Phase 1
Completed
- Conditions
- NASH - Nonalcoholic Steatohepatitis
- Interventions
- Other: Placebo
- First Posted Date
- 2021-05-21
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- Terns, Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT04897594
- Locations
- 🇺🇸
Terns Clinical Study Site 1018, Tucson, Arizona, United States
🇺🇸Terns Clinical Study Site 1024, Tucson, Arizona, United States
🇺🇸Terns Clinical Study Site 1001, Panorama City, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath